These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rational therapy of nephrolithiasis, Part II. Pak CY Ration Drug Ther; 1984 Dec; 18(12):1-7. PubMed ID: 6536978 [No Abstract] [Full Text] [Related]
23. An unusual patient with hypercalciuria, recurrent nephrolithiasis, hypomagnesemia and G227R mutation of Paracellin-1. An unusual patient with hypercalciuria and hypomagnesemia unresponsive to thiazide diuretics. Kutluturk F; Temel B; Uslu B; Aral F; Azezli A; Orhan Y; Konrad M; Ozbey N Horm Res; 2006; 66(4):175-81. PubMed ID: 16804318 [TBL] [Abstract][Full Text] [Related]
24. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
26. Kidney stones: current issues in diagnosis and therapy. Brown DC Postgrad Med; 1982 Dec; 72(6):124-33. PubMed ID: 6755415 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic measures in recurrent calcium oxalate nephrolithiasis]. Tschöpe W; Schmidt-Gayk H; Ritz E Schweiz Rundsch Med Prax; 1978 Sep; 67(38):1385-8. PubMed ID: 211499 [No Abstract] [Full Text] [Related]
28. The first kidney stone. Uribarri J; Oh MS; Carroll HJ Ann Intern Med; 1989 Dec; 111(12):1006-9. PubMed ID: 2688503 [TBL] [Abstract][Full Text] [Related]
29. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Strauss AL; Coe FL; Deutsch L; Parks JH Am J Med; 1982 Jan; 72(1):17-24. PubMed ID: 7058820 [TBL] [Abstract][Full Text] [Related]
30. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY; Sakhaee K; Fuller CJ Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957 [TBL] [Abstract][Full Text] [Related]
31. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979 [TBL] [Abstract][Full Text] [Related]
32. Kidney stone disease: evaluation and medical management. Derrick FC; Carter WC Postgrad Med; 1979 Oct; 66(4):115-9, 122-5. PubMed ID: 482169 [TBL] [Abstract][Full Text] [Related]
33. Medical management of nephrolithiasis. Saklayen MG Med Clin North Am; 1997 May; 81(3):785-99. PubMed ID: 9167658 [TBL] [Abstract][Full Text] [Related]
34. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis. Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199 [TBL] [Abstract][Full Text] [Related]
35. [Therapy of nephrolithiasis]. Tschöpe W; Ritz E Dtsch Med Wochenschr; 1985 Mar; 110(10):385-8. PubMed ID: 3971867 [No Abstract] [Full Text] [Related]
36. Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate. Hallson PC; Kasidas GP; Rose GA Urol Res; 1976; 4(4):169-73. PubMed ID: 1020068 [TBL] [Abstract][Full Text] [Related]
37. Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"? Preminger GM Semin Urol; 1994 Feb; 12(1):51-64. PubMed ID: 8197337 [No Abstract] [Full Text] [Related]
39. A new urinary test for stone "activity". Hallson PC; Rose GA Br J Urol; 1978 Dec; 50(7):442-8. PubMed ID: 753493 [TBL] [Abstract][Full Text] [Related]